HomeInsightsDividend

Remus Pharmaceuticals Ltd dividend

Remus Pharmaceuticals Ltd dividend

download
stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

0.9 K

stocks traded

Last Updated time: 23 Jul 10:27 AM

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

DPS

2

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Remus Pharmaceuticals Ltd is ₹ 2 as of 2023 .a1#The Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2020 to 2.56 % on March 2023 . This represents a CAGR of 0.00% over 1 years. a1#The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 1935 as of 23 Jul 10:09 .a1#The Market Cap of Remus Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 4 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot
×

Historical Dividend Payout of Remus Pharmaceuticals Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Remus Pharmaceuticals Ltd

Period
Mar '200
Mar '210
Mar '220
Mar '233

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PRICE

1935

-27.35 (-1.39%)

stock direction

Last updated : 23 Jul 10:09

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Remus Pharmaceuticals Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Remus Pharmaceuticals Ltd

Period
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in crore

About Remus Pharmaceuticals Ltd

About Remus Pharmaceuticals Ltd

    Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a private limited company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a private company to public company and consequently, the name of Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet. The core business of the Company into three categories, which comprise of Manufacturing, through loan licencse or on contract manufacturing bassis, of approved finished formulations and distribution of the same in various countries; Trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers.The product portfolio comprises of therapeutic drugs like ACE inhibitors, anaesthetic, Anti histamine, Antifungal, Anti-inflammatory, Antibiotic, Antidiabetic, Antipsychotic, Antiretroviral, Chronic Obstructive Pulmonary Disease, Asthma, Carcinoid tumours, CNS stimulants, Nasal decongestants, Potassium deficiency, Probiotic, Antispasmodic, Ocular-hypertension, Urology and Vitamin deficiency. The Pharma business operations are supported by various contract manufacturers having facilities which are WHO GMP Compliant. The core strength lies in getting approved formulation manufactured through contract manufacturers under loan licence and marketing of formulations through marketing network across geographies.The product portfolio consists of 429 products, as on January 31, 2023. The Company has business to business supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply. The Company is proposing an initial public issue consisting of upto 388000 Equity Shares through Fresh Issue.

Remus Pharmaceuticals Ltd News Hub

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

10 May 202412:07

News

Remus Pharmaceuticals schedules EGM

Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

24 Apr 202410:34

News

Remus Pharmaceuticals revises board meeting date

Remus Pharmaceuticals has revised the meeting of the Board of Directors which was schedule...

Read more

20 Apr 202415:16

News

Remus Pharmaceuticals to consider Dividend

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 A...

Read more

17 Apr 202409:39

News

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

20 Oct 202316:09

News

Remus Pharmaceuticals to conduct board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 19 O...

Read more

14 Oct 202314:55

up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199